Results 21 to 30 of about 621,963 (341)

Fetal polycystic kidney disease: Pathological overview

open access: yesJournal of the Scientific Society, 2013
Polycystic kidney disease is a rare developmental anomaly inherited as autosomal dominant or autosomal recessive. It is characterized by cystic dilatation of the collecting ducts frequently associated with hepatic involvement and progression to renal ...
Sunita B Patil   +3 more
doaj   +1 more source

Traumatic Kidney in a Patient With Unilateral Renal Cystic Disease

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2022
Renal trauma occurring in patients with unilateral renal cystic disease (URCD) is extremely rare. Unilateral renal cystic disease is benign, nonprogressive, nonfamilial, nonencapsulated, and unrelated to cysts in other organs. It should be differentiated
Van Trung Hoang MD   +5 more
doaj   +1 more source

A rare cause of recurrent spontaneous pneumothorax: Birt-hogg-dube syndrome [PDF]

open access: yes, 2018
Birt-Hogg-Dube (BHD) syndrome is an unusual disorder characterized by the triad of cutaneous lesions, renal tumors and lung cysts. In cases with BHD syndrome, the frequency of recurrent pneumothorax is increased due to presence of multiple lung cysts. It
Demirci, M.   +3 more
core   +1 more source

Caffeine Accelerates Cystic Kidney Disease in a Pkd1-Deficient Mouse Model.

open access: yesCellular Physiology and Biochemistry, 2019
BACKGROUND/AIMS Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive cyst formation and growth, leading to end-stage renal disease. A higher kidney volume is predictive of a more accelerated decline in renal function. This
R. Meca   +7 more
semanticscholar   +1 more source

Dual mTOR/PI3K inhibition limits PI3K-dependent pathways activated upon mTOR inhibition in autosomal dominant polycystic kidney disease [PDF]

open access: yes, 2018
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the development of kidney cysts leading to kidney failure in adulthood. Inhibition of mammalian target of rapamycin (mTOR) slows polycystic kidney disease (PKD) progression in ...
Arcaro, Alexandre   +10 more
core   +2 more sources

Defining cellular complexity in human autosomal dominant polycystic kidney disease by multimodal single cell analysis

open access: yesbioRxiv, 2021
Autosomal dominant polycystic kidney disease (ADPKD) is the leading genetic cause of end stage renal disease and is characterized by the formation and progressive expansion of kidney cysts. Most ADPKD cases arise from mutations in either the PKD1 or PKD2
Yoshiharu Muto   +15 more
semanticscholar   +1 more source

Multiple Gastric Carcinomas Associated with Potter Type III Cystic Disease

open access: yesCase Reports in Gastroenterology, 2011
We report a case of multiple gastric carcinomas associated with Potter type III cystic disease of the liver, mesenterium and kidney. A 65-year-old man with chronic renal failure due to polycystic kidneys and under hemodialysis treatment 3 times a week ...
Kenji Mimatsu   +7 more
doaj   +1 more source

Nephronophthisis and medullary cystic kidney disease complex [PDF]

open access: yesVojnosanitetski Pregled, 2005
Background. Nephronophthisis and medullary cystic kidney disease complex refers to the genetic heterogeneous group of inherited tubulointerstital nephritis. Nephronophthisis comprises at last 3 clinical manifestations, has the autosomal recessive pattern
Stanišić Marijana   +3 more
doaj   +1 more source

La risonanza magnetica pesata in diffusione (DWI) per la quantificazione del volume delle cisti e la caratterizzazione del tessuto non cistico nella malattia policistica renale: lo studio dell’Istituto Mario Negri

open access: yesGiornale di Clinica Nefrologia e Dialisi, 2023
Beyond total kidney and cyst volume, non-cystic tissue plays an important role in autosomal dominant polycystic kidney disease (ADPKD) progression.
Ariela Benigni
doaj   +1 more source

Measuring the burden of treatment for chronic disease: implications of a scoping review of the literature [PDF]

open access: yes, 2017
Background: Although there has been growing research on the burden of treatment, the current state of evidence on measuring this concept is unknown.
Mair, Frances S.   +3 more
core   +3 more sources

Home - About - Disclaimer - Privacy